Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02615535 · ClinicalTrials.gov registry record · NA
Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02615535 is a NA study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 25 participants.
The verdict
NCT02615535, a NA study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in cultivating a relaxed, attentive state of mind during meditation. The investigators study aims to evaluate whether such a tool could be useful in treating persistent traumatic brain injury symptoms such as inattention, impulsivity, irritability, or dysregulated mood.
Interventions
- DEVICE EEG neurofeedback-assisted meditation
- DEVICE Non-EEG feedback-assisted meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02615535
The ClinicalTrials.gov registry entry for NCT02615535 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EEG neurofeedback-assisted meditation is the first listed.
NCT02615535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02615535 about?
NCT02615535 is a clinical study titled "Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury". Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in cultivating a relaxed, attentive state of mind during meditation. The investigators study aims to evaluate wheth...
What is the current status of trial NCT02615535?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02615535?
The interventions under investigation include: EEG neurofeedback-assisted meditation (DEVICE), Non-EEG feedback-assisted meditation (DEVICE).
Who is sponsoring clinical trial NCT02615535?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.